Paul KAUFFMANN

MagIA is developing a multi-analyis "Point-of-Care" that can be used outside of any clinical environment. With a first focus on infectious diseases MagIA is providing a syndromic testing approach at the Point of Care outside of traditional clinical environment. With the motto “a better screening for a better care", MagIA focuses first on the rapid detection of infectious diseases, starting with an HIV-Viral Hepatitis combo, to link to care Key « high-risk » populations. MagIA's innovation is a one-step no-wash immunoassay method which brings unique characteristics: (1) laboratory quality on a portable device, usable indoor, outdoor, (2) 8 analyses in parallel with 1 single fingerpick, for a syndromic diagnostic approach (3) secured analysis and traceable results.